POST Online Media Lite Edition


Transgenomic appointed new board members

Staff writer |
Omaha, Neb., USA - May 23, 2009, Omaha, Neb., USA - Transgenomic, Inc. announces that it has appointed Antonius P. Schuh and Michael B. McNulty to its Board of Directors.

Article continues below

Dr. Schuh is the Founding Chairman and Chief Executive Officer of Sorrento Therapeutics, Inc. (STI). Prior to STI, Dr. Schuh was the Founding Chief Executive Officer and Director of AviaraDx, Inc. AviaraDx was a molecular diagnostics laboratory company focused on oncology testing which was acquired by bioMerieux. Before leading AviaraDx, Dr. Schuh was Chief Executive Officer of Arcturus Bioscience, Inc. and Sequenom, Inc.


What to read next

Hitachi appoints chairman
Chairman and members of the board of the Dubai Financial Support Fund appointed
Petrol: Four board members to step down